tiprankstipranks
DocGo (DCGO)
NASDAQ:DCGO
US Market
Holding DCGO?
Track your performance easily

DocGo (DCGO) Earnings Date & Reports

513 Followers

Earnings Data

Report Date
Mar 17, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$0.04
Last Year’s EPS
$0.08
Same Quarter Last Year
Based on 5 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 07, 2024
|
% Change Since: 24.93%
|
Next Earnings Date:Mar 17, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed outlook with strong performance and strategic expansions being offset by revenue declines and increased expenses related to the winding down of migrant-related projects. While financial targets are being met and new contracts are being signed, there are challenges in transitioning resources and maintaining margins.
Company Guidance
During the Q3 2024 earnings call for DocGo, the company provided detailed guidance and financial metrics, reflecting significant progress and future expectations. DocGo recorded $138.7 million in revenue and $17.9 million in adjusted EBITDA for the quarter. The company projects its 2024 revenue to be between $620 million and $630 million, with adjusted EBITDA ranging from $70 million to $75 million. Cash flow from operations is expected to increase to between $90 million and $100 million. Migrant-related revenues are projected to reach $360 million to $390 million in 2024, with a corresponding reduction in non-migrant municipal health programs, maintaining consolidated revenue expectations. For 2025, DocGo anticipates consolidated revenue between $410 million and $450 million, including an expected $50 million from migrant-related services. The company highlighted its strategic expansions, particularly in its care gap closure programs, which have seen a significant increase in assigned lives and are expected to reach a run rate of 1,000 visits per week by year-end. Additionally, DocGo's cash and cash equivalents have grown to over $108 million, underscoring strong cash flow trends.
Strong Performance in Q3 2024
DocGo recorded $138.7 million in revenue and $17.9 million in adjusted EBITDA. The company has more than doubled the number of assigned lives in their care gap closure programs, now exceeding 500,000 patients.
Increased Guidance for 2024
2024 revenue guidance has been fine-tuned to $620 million to $630 million, and adjusted EBITDA is expected to be $70 million to $75 million. Cash flow from operations is now projected to be $90 million to $100 million, up from $80 million to $90 million.
Successful Expansion and New Contracts
DocGo is expanding its care gap closure programs and has signed an expansion deal with L.A. Care to provide transitional care management and other services.
Strong Cash Position
DocGo's cash and cash equivalents increased to over $108 million, up from $86 million last quarter and $59 million in Q1 of 2024.
Improved Gross Margins
The adjusted gross margin was 36%, up from 29.5% in Q3 2023. Mobile Health segment margins improved to 38.8% from 28.8%.
---

DocGo (DCGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DCGO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 17, 20252024 (Q4)
0.04 / -
0.075
Nov 07, 20242024 (Q3)
0.04 / 0.05
0.050.00% (0.00)
Aug 07, 20242024 (Q2)
0.06 / 0.06
-0.02400.00% (+0.08)
May 08, 20242024 (Q1)
0.08 / 0.10
-0.03433.33% (+0.13)
Feb 28, 20242023 (Q4)
0.10 / 0.07
0.11-31.82% (-0.04)
Nov 06, 20232023 (Q3)
0.06 / 0.05
0.0366.67% (+0.02)
Aug 07, 20232023 (Q2)
0.03 / -0.02
0.11-118.18% (-0.13)
May 08, 20232023 (Q1)
0.02 / -0.03
0.09-133.33% (-0.12)
Mar 13, 20232022 (Q4)
0.07 / 0.11
0.25-56.00% (-0.14)
Nov 07, 20222022 (Q3)
0.04 / 0.03
0.030.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

DCGO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$3.61$4.00+10.80%
Aug 07, 2024$2.99$3.63+21.40%
May 08, 2024$3.50$3.08-12.00%
Feb 28, 2024$3.94$4.07+3.30%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does DocGo (DCGO) report earnings?
DocGo (DCGO) is schdueled to report earning on Mar 17, 2025, TBA Not Confirmed.
    What is DocGo (DCGO) earnings time?
    DocGo (DCGO) earnings time is at Mar 17, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DCGO EPS forecast?
          DCGO EPS forecast for the fiscal quarter 2024 (Q4) is $0.04.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis